These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 10423656)
1. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension. Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. Fogari R; Zoppi A; Lazzari P; Mugellini A; Lusardi P; Preti P; Van Nueten L; Vertommen C J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension. Germino FW Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials. Weiss RJ; Saunders E; Greathouse M Clin Ther; 2011 Sep; 33(9):1150-61. PubMed ID: 21864908 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial. Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075 [TBL] [Abstract][Full Text] [Related]
6. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension. Simon G; Johnson ML Clin Exp Hypertens; 1993 May; 15(3):501-9. PubMed ID: 8098243 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study. Rosei EA; Rizzoni D; Comini S; Boari G; Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985 [TBL] [Abstract][Full Text] [Related]
8. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study. Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690 [TBL] [Abstract][Full Text] [Related]
9. Nebivolol in the management of essential hypertension: a review. McNeely W; Goa KL Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study. Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M; Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension. Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311 [TBL] [Abstract][Full Text] [Related]
12. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients. Poirier L; Cléroux J; Nadeau A; Lacourcière Y J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851 [TBL] [Abstract][Full Text] [Related]
13. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial. Lewin A; Punzi H; Luo X; Stapff M Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension. Germino FW; Lin Y; Pejović V; Bowen L Ther Adv Cardiovasc Dis; 2012 Oct; 6(5):185-99. PubMed ID: 23008339 [TBL] [Abstract][Full Text] [Related]
15. Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension. Neutel JM; Smith DH; Gradman AH J Hum Hypertens; 2010 Jan; 24(1):64-73. PubMed ID: 19404314 [TBL] [Abstract][Full Text] [Related]
16. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial. Weiss RJ; Stapff M; Lin Y Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546 [TBL] [Abstract][Full Text] [Related]
17. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study. Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486 [TBL] [Abstract][Full Text] [Related]
18. Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. Fratta Pasini A; Garbin U; Nava MC; Stranieri C; Davoli A; Sawamura T; Lo Cascio V; Cominacini L J Hypertens; 2005 Mar; 23(3):589-96. PubMed ID: 15716701 [TBL] [Abstract][Full Text] [Related]
19. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. Deedwania P; Shea J; Chen W; Brener L J Clin Hypertens (Greenwich); 2013 Apr; 15(4):270-8. PubMed ID: 23551727 [TBL] [Abstract][Full Text] [Related]
20. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial. Van Nueten L; Taylor FR; Robertson JI J Hum Hypertens; 1998 Feb; 12(2):135-40. PubMed ID: 9504355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]